Metraipolis › archive › dc_f09cb7393fac

Outcomes of real-world initiation of long-acting injectable cabotegravir and rilpivirine (LA-I CAB + RPV) in individuals with viraemia: A systematic review of… — Europe PMC PMID:40944511

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/40944511
DOI: 10.1111/hiv.70113
License (as archived): solo-consultazione
Archived: 2026-11-09T23:34:38.752Z
SHA-256 of the archived text: bf18531ccd167a6c1551ce66f39f21fc8aa078058ddfea6f35056f799d700148
Stable URL of this page: https://metraipolis.com/documento/dc_f09cb7393fac

How to cite

Outcomes of real-world initiation of long-acting injectable cabotegravir and rilpivirine (LA-I CAB + RPV) in individuals with viraemia: A systematic review of… — Europe PMC PMID:40944511 — Europe PMC (en), https://europepmc.org/article/MED/40944511 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f09cb7393fac (Metraipolis archive dc_f09cb7393fac, sha256 bf18531ccd167a6c1551ce66f39f21fc8aa078058ddfea6f35056f799d700148)

BibTeX

@misc{dcf09cb7393fac,
  title = {Outcomes of real-world initiation of long-acting injectable cabotegravir and rilpivirine (LA-I CAB + RPV) in individuals with viraemia: A systematic review of… — Europe PMC PMID:40944511},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40944511},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f09cb7393fac; sha256 bf18531ccd167a6c1551ce66f39f21fc8aa078058ddfea6f35056f799d700148},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40944511. Agents can read the archived copy with the MCP tool read_document.